Back to Search
ABRAHAM FURA, D.O.
D.O.
Pain Medicine (Anesthesiology) Physician
NPI: 1275843914Individual
Specialties, Licenses & Credentials
Anesthesiology Physician
Anesthesiology
Code: 207L00000X
0102203028(VA)
Pain Medicine (Anesthesiology) PhysicianPrimary
Anesthesiology — Pain Medicine
Code: 207LP2900X
OS16143(FL)
Research & Publications (15)
Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections.
PMID 19251818·Drug Metab Dispos·2009
7-preclinical
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation.
PMID 19351168·J Med Chem·2009
7-preclinical
Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
PMID 18989850·Biopharm Drug Dispos·2008
7-preclinical
Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists.
PMID 18291644·Bioorg Med Chem Lett·2008
7-preclinical
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.
PMID 17008401·Endocrinology·2007
7-preclinical
Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
PMID 17552509·J Med Chem·2007
7-preclinical
Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators.
PMID 17292608·Bioorg Med Chem Lett·2007
7-preclinical
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold.
PMID 17181141·J Med Chem·2006
7-preclinical
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor.
PMID 16570908·J Med Chem·2006
7-preclinical
Role of pharmacologically active metabolites in drug discovery and development.
PMID 16533711·Drug Discov Today·2006
6-review
Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors.
PMID 15943473·J Med Chem·2005
7-preclinical
Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.
PMID 15713401·Bioorg Med Chem Lett·2005
7-preclinical
A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo.
PMID 15637285·Endocrinology·2005
7-preclinical
Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery.
PMID 15317447·J Med Chem·2004
6-review
Shift in pH of biological fluids during storage and processing: effect on bioanalysis.
PMID 14565556·J Pharm Biomed Anal·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 12276 SAN JOSE BLVD STE 210
JACKSONVILLE, FL 32223 - Phone
- (904) 717-9625
Quick Facts
- NPI
- 1275843914
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 3
- Publications
- 15
Are you this provider?
Claim Your Profile